Cargando…

Advances in Radiotherapy Management of Esophageal Cancer

Radiation therapy (RT) as part of multidisciplinary oncologic care has been marked by profound advancements over the past decades. As part of multimodality therapy for esophageal cancer (EC), a prime goal of RT is to minimize not only treatment toxicities, but also postoperative complications and ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Vivek, Moreno, Amy C., Lin, Steven H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086593/
https://www.ncbi.nlm.nih.gov/pubmed/27775643
http://dx.doi.org/10.3390/jcm5100091
_version_ 1782463758800519168
author Verma, Vivek
Moreno, Amy C.
Lin, Steven H.
author_facet Verma, Vivek
Moreno, Amy C.
Lin, Steven H.
author_sort Verma, Vivek
collection PubMed
description Radiation therapy (RT) as part of multidisciplinary oncologic care has been marked by profound advancements over the past decades. As part of multimodality therapy for esophageal cancer (EC), a prime goal of RT is to minimize not only treatment toxicities, but also postoperative complications and hospitalizations. Herein, discussion commences with the historical approaches to treating EC, including seminal trials supporting multimodality therapy. Subsequently, the impact of RT techniques, including three-dimensional conformal RT, intensity-modulated RT, and proton beam therapy, is examined through available data. We further discuss existing data and the potential for further development in the future, with an appraisal of the future outlook of technological advancements of RT for EC.
format Online
Article
Text
id pubmed-5086593
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-50865932016-11-02 Advances in Radiotherapy Management of Esophageal Cancer Verma, Vivek Moreno, Amy C. Lin, Steven H. J Clin Med Review Radiation therapy (RT) as part of multidisciplinary oncologic care has been marked by profound advancements over the past decades. As part of multimodality therapy for esophageal cancer (EC), a prime goal of RT is to minimize not only treatment toxicities, but also postoperative complications and hospitalizations. Herein, discussion commences with the historical approaches to treating EC, including seminal trials supporting multimodality therapy. Subsequently, the impact of RT techniques, including three-dimensional conformal RT, intensity-modulated RT, and proton beam therapy, is examined through available data. We further discuss existing data and the potential for further development in the future, with an appraisal of the future outlook of technological advancements of RT for EC. MDPI 2016-10-21 /pmc/articles/PMC5086593/ /pubmed/27775643 http://dx.doi.org/10.3390/jcm5100091 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Verma, Vivek
Moreno, Amy C.
Lin, Steven H.
Advances in Radiotherapy Management of Esophageal Cancer
title Advances in Radiotherapy Management of Esophageal Cancer
title_full Advances in Radiotherapy Management of Esophageal Cancer
title_fullStr Advances in Radiotherapy Management of Esophageal Cancer
title_full_unstemmed Advances in Radiotherapy Management of Esophageal Cancer
title_short Advances in Radiotherapy Management of Esophageal Cancer
title_sort advances in radiotherapy management of esophageal cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086593/
https://www.ncbi.nlm.nih.gov/pubmed/27775643
http://dx.doi.org/10.3390/jcm5100091
work_keys_str_mv AT vermavivek advancesinradiotherapymanagementofesophagealcancer
AT morenoamyc advancesinradiotherapymanagementofesophagealcancer
AT linstevenh advancesinradiotherapymanagementofesophagealcancer